Elsevier

Talanta

Volume 144, 1 November 2015, Pages 136-144
Talanta

A non-invasive genomic diagnostic method for bladder cancer using size-based filtration and microchip electrophoresis

https://doi.org/10.1016/j.talanta.2015.05.065Get rights and content

Highlights

  • Bladder cancer cells in urine were captured by size-based filtration device.

  • Cell capture-PCR and microchip electrophoresis method were combined.

  • A non-invasive genomic diagnostic method for bladder cancer was developed.

Abstract

Bladder cancer (BC) cells spontaneously exfoliated in the urine of patients with BC. Detection of exfoliated tumor cells has clinical significance in cancer therapy because it would enable earlier non-invasive screening, diagnosis, or prognosis of BC. In this research, a method for analyzing genetic abnormalities of BC cells collected from urine samples was developed. Target BC cells were isolated by filtration. To find conditions that achieve high cell recovery, we investigated the effects of filter type, concentration of fixative, and flow rate. Cells captured on the filter membrane were completely retrieved within 15 s. Selected genes for genomic analysis, mutated genes (FGFR3, TERT and HRAS) and methylated genes (ALX4, RALL3, MT1A, and RUNX3) were amplified by polymerase chain reaction (PCR), and subsequently, were identified by microchip electrophoresis (MCE). Analysis by MCE reduces the risk of contamination, sample consumption, and analysis time. Our developed approach is economical, effectively isolates cancer cells, and permits flexible molecular characterization, all of which make this approach a promising method for non-invasive BC detection.

Graphical abstract

Genomic analysis of bladder cancer using a combined cell capture-specific polymerase chain reaction–microchip electrophoresis system.

  1. Download : Download full-size image

Introduction

Bladder cancer (BC) is commonly diagnosed in developed countries [1], and is increasingly being diagnosed in developing countries [2]. Upon detection, approximately 75% of bladder cancer tumors are classified as non-muscle invasive BC (NMI-BC). NMI-BC typically recurs after treatment, and in 15–20% of the cases, progresses to muscle-invasive BC (MI-BC) [3], [4]. Therefore, patients who have had BC require regular monitoring for recurrence and progression. BC screening and surveillance is traditionally performed with cystoscopy and cytology, each having certain disadvantages. Cystoscopy is an invasive and unpleasant procedure for patients, and although urine cytology has good specificity, it has a poor sensitivity for detection of low-grade BC [5]. Therefore, a sensitive and non-invasive method for BC detection is greatly needed.

Voided urine is an ideal sample for non-invasive BC diagnosis since malignant cells are exfoliated spontaneously when tumors grow. Recently, several non-invasive urine tests for BC have been approved by the Food and Drug Administration (FDA); however, they are not commonly used in clinical practice due to low sensitivity or specificity [6]. Since cancer cells will be scarce in urine, an efficient cell isolation method is needed to improve the sensitivity. Traditional pretreatment methods for BC cells isolation from urine like centrifugation are often associated with significant cell loss [7]. To avoid such cell loss, numerous cell isolation methods have been developed to instead rely on physical or immunochemical properties [8], [9]. For example, filtration methods, which are based on variations in both cell size and deformability, provide fast cell isolation from large volume samples and remove the complex background matrix before downstream analysis. One such isolation method using track-etched polycarbonate membrane (PC membrane), originally developed by Vona et al. [10] for epithelial tumor cells (ISET), has been extensively applied to the detection of many kinds of cancers [11], [12], [13], [14]. These microfilters of controlled pore distribution, size, and geometry are available in a variety of materials [15], [16], [17], [18]. Methods using membranes to isolate cancer cells have shown great results, but have mostly been developed for the isolation of circulating tumor cells (CTCs) in peripheral blood [11], [12], [13], [14], [15], [16], [17], [18] as opposed to urine samples [19], [20].

Though size-based filtration devices can isolate target cells from urine with high speed, most require that the isolated cells on the membrane be identified by immunostaining [18], [20]. The process of fixing, immunostaining, and subsequently imaging is laborious and subjective. An alternative method for identifying the isolated cells is by automatically analyzing tumor-associated genomic alterations in DNA [21]. Somatic mutations and hypermethylation of promoter CpG islands in specific genes have been confirmed to be responsible for the transformation of a normal cell into cancer [22], and are promising biomarkers for cancer detection. The most frequently mutated genes include fibroblast growth factor receptor 3 (FGFR3) [23], [24] and telomerase reverse transcriptase (TERT) [25], [26]. Furthermore, epigenetic perturbation of gene regulation is increasingly being shown to cause early tumorigenesis [27], [28]. However, merely applying gene mutation or methylation analysis alone is insufficient to define all types of BC, and different studies have reported highly variable levels of specificity and sensitivity, even for identical markers [29]. Thus, a combination of gene mutation and methylation analysis is recommended to detect BC in clinical samples [30]. Traditional non-invasive BC genomic diagnostic assays consist of genomic sequencing or polyacrylamide gel electrophoresis (PAGE) separation after PCR amplification [16], [19], [20], [31]. Genomic sequencing is time-consuming and costly while the PAGE method is subject to tedious manual operations as well as DNA contamination and low sensitivity, both of which may lead to false results. Most recently, MCE is being explored as a replacement for PAGE for analyzing DNA fragments [32]. Although MCE separations have been used in various biochemical and chemical applications [33], [34], [35], few analytical methods have been reported for clinical diagnosis thus far.

The aim of this study was to develop a sensitive and cost-effective cell capture-PCR–MCE system (CCPM) for non-invasive detection of BC. Briefly, BC cells were isolated from urine by a size-based filtration device (Fig. 1A). After cell retrieval and subsequent lysis, target genes were amplified by PCR for gene mutation and methylation analysis (Fig. 1B). A simple and rapid MCE system was utilized to further detect target gene fragments (Fig. 1C). Combining the merits of filtration devices and MCE technology, this system showed good performance in cell recovery and high sensitivity for the detection of genomic alterations, without using expensive instruments and reagents. The developed method is well-qualified in linearity, sensitivity, and repeatability for clinical application for BC detection.

Section snippets

Materials and reagents

PC membranes were purchased from Whatman Nucleopore (GE, Kent, UK). The nickel microsieve was manufactured by Shanben Precision Co., Ltd. (Guangzhou, China). Hoechst 33342 and LIVE/DEAD® Cell Viability Kit were purchased from Invitrogen Co., Ltd. (Shanghai, China). Dichloromethane (99.8%, AR) was purchased from Sigma-Aldrich (Shanghai, China). All primers were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). PCR reagents including 10×PCR Buffer, 25 mM MgCl2, 10 mM dNTPs and HotStart Taq

Rapid BC cell isolation and retrieval

PC membranes and nickel microsieves were used to capture cells. As shown in Fig. 2, the thickness of PC membrane was 10 µm and the diameters of pores were 8 µm. At the top surface, the nickel microsieve had pores of 8 µm diameter arranged in parallel with a distance of 50 µm between them. A total of 57,600 pores were arranged in the center within a circle of a diameter of 25 mm. The typical diameters of background cells are 5–8 µm for RBCs and 10–15 µm for WBCs. Prevails study on demonstrated that

Conclusion

In this work, a rapid and sensitive method for non-invasive BC detection was developed. This cell capture-PCR–MCE system shows several advantages over current BC detection methods. Firstly, a filtration step improves the efficiency of isolating cancer cells and also reduces contaminants. Secondly, DNA mutation and methylation analysis were combined in one diagnostic panel for multi-marker BC detection. Finally, MCE separation reduces reagent consumption and achieves high-throughput analysis

Acknowledgment

This work was supported by National Natural Science Foundation of China (Nos. 91213305 and 81373373).

References (50)

  • G. Gakis et al.

    Eur. Urol.

    (2013)
  • M. Babjuk et al.

    Eur. Urol.

    (2013)
  • D. Tilki et al.

    Eur. Urol.

    (2011)
  • H. Esmaeilsabzali et al.

    Biotechnol. Adv.

    (2013)
  • G. Vona et al.

    Am. J. Pathol.

    (2000)
  • P. Pinzani et al.

    Hum. Pathol.

    (2006)
  • V. De Giorgi et al.

    J. Invest. Dermatol.

    (2010)
  • S. Zheng et al.

    J. Chromatogr. A

    (2007)
  • M. Birkhahn et al.

    Eur. J. Cancer

    (2013)
  • Z. Herceg et al.

    Mol. Oncol.

    (2007)
  • K.E.M. van Kessel et al.

    J. Urol.

    (2013)
  • Y. Allory et al.

    Eur. Urol.

    (2014)
  • R.J. Karnes et al.

    Mayo Clin. Proc.

    (2012)
  • M.C. Breadmore

    J. Chromatogr. A

    (2012)
  • X. Li et al.

    J. Chromatogr. A

    (2013)
  • N. Nuchtavorn et al.

    J. Chromatogr. A

    (2013)
  • M. Wu et al.

    Talanta

    (2015)
  • X.X. Lin et al.

    Talanta

    (2013)
  • T. Huang et al.

    Biosens. Bioelectron.

    (2014)
  • N.J. Toyang et al.

    J. Ethnopharmacol.

    (2013)
  • P. Gazzaniga et al.

    Ann. Oncol.

    (2012)
  • R. Siegel et al.

    Cancer statistics, 2014, CA

    Cancer J. Clin.

    (2014)
  • W.Q. Chen et al.

    Chin. Cancer

    (2014)
  • R. Burger et al.

    Eur. Urol.

    (2013)
  • P. Bories et al.

    Clin. Chem.

    (2013)
  • Cited by (18)

    • Visual detection of high-risk HPV16 and HPV18 based on loop-mediated isothermal amplification

      2020, Talanta
      Citation Excerpt :

      Further DNA testing should be performed if other samples are to be examined for the presence of HPV virus infection. The performance of the microchip electrophoresis system in detecting DNA has been verified in previous studies by Lin's group [23–27]. A schematic illustration of the microchip electrophoresis mechanism is shown in Fig. S2.

    • Rapid detection of high-risk HPV16 and HPV18 based on microchip electrophoresis

      2020, Journal of Pharmaceutical Analysis
      Citation Excerpt :

      Briefly, HPV DNA was amplified using general primers and type-specific primers to achieve detectable levels and the PCR amplification products detection was performed on a microchip electrophoresis system. The reliability of the MCE system in DNA and RNA analysis has been verified in previous studies of Lin group [14–17]. Two cervical cancer cell lines, CaSki cells and Hela cells, were supplied from Cancer Institute and Hospital of Chinese Academy of Medical Science (Beijing, China).

    • Microfluidic chip and its application in autophagy detection

      2019, TrAC - Trends in Analytical Chemistry
      Citation Excerpt :

      The constructed in vitro MC models, which directly or indirectly combines with other analytical equipment, have strong compatibility. As an indirect carrier for in vivo and in vitro studies, MC can be used as a means of precisely operation to perform single-cell analysis [57,58], cell behavior observation [59] and cancer cell isolation [60]. Additionally, a variety of tissue or organ chips have now been used to simulate the pathogenesis, pathophysiology, and the diagnosis and treatment process of diverse diseases [50,59,61–63].

    • A decade of microchip electrophoresis for clinical diagnostics – A review of 2008–2017

      2019, Analytica Chimica Acta
      Citation Excerpt :

      This assay was evaluated on serum samples from healthy subjects and ovarian cancer patients and analyte concentrations of 9.5–15.7 mIU mL−1 and 160.9–210.4 mIU mL−1 were found in healthy and cancer samples, respectively. Bladder cancer was studied by multiplexed microfluidic immunoassay using DEP [92,93] and MGE-LIF [94]. The biomarker panel included galectin-1, lactate dehydrogenase B, and bladder cancer-specific genes FGFR3, TERT, HRAS, ALX4, RALL3, MT1A, and RUNX3.

    • Electrophoresis of a Single Rigid Particle

      2019, Interface Science and Technology
      Citation Excerpt :

      In addition to the separation function, it can also be used to explore the surface electric condition of colloidal particles, hence test the validity of associated theories regarding it [35, 36]. Other technologies and advances based on electrophoresis are abundant as well in the last decade [37–43]. With such a powerful capability and great potential in practical applications, yet the underlying physical principle of electrophoresis is very simple and easy to understand: the force balance between the electric driving force and the hydrodynamic drag force.

    View all citing articles on Scopus
    View full text